{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:13:34Z","timestamp":1778541214663,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["697-130-2024"],"award-info":[{"award-number":["697-130-2024"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.prp.2025.155876","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:22:40Z","timestamp":1740741760000},"page":"155876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["6-Paradol enhances sorafenib's effects against colorectal cancer and promotes active metabolite formation"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4642-2244","authenticated-orcid":false,"given":"Mohamed G.","family":"Mehanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-1674","authenticated-orcid":false,"given":"Ali M.","family":"El-Halawany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-4867","authenticated-orcid":false,"given":"Ahmed M.","family":"Al-Abd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-9848","authenticated-orcid":false,"given":"May M.","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam A.","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-5219","authenticated-orcid":false,"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2223-3031","authenticated-orcid":false,"given":"Salwa D.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-0679","authenticated-orcid":false,"given":"Azizah Salim","family":"Bawadood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-3512","authenticated-orcid":false,"given":"Firoz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-4913","authenticated-orcid":false,"given":"Fahad A.","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prp.2025.155876_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2025.155876_bib3","first-page":"18","article-title":"Timing your apoptosis assays","volume":"16","author":"Sundquist","year":"2006","journal-title":"Cell Notes"},{"issue":"10207","key":"10.1016\/j.prp.2025.155876_bib4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"issue":"11-12","key":"10.1016\/j.prp.2025.155876_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.prp.2025.155876_bib6","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.18203\/2320-6012.ijrms20174914","article-title":"Colorectal cancer: a review","volume":"5","author":"Granados-Romero","year":"2017","journal-title":"Int. J. Res. Med. Sci."},{"key":"10.1016\/j.prp.2025.155876_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-017-9726-5","article-title":"Mutations of key driver genes in colorectal cancer progression and metastasis","volume":"37","author":"Huang","year":"2018","journal-title":"Cancer Metastas. Rev."},{"issue":"2","key":"10.1016\/j.prp.2025.155876_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of colorectal carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2025.155876_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.prp.2025.155876_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110170","article-title":"Colon cancer and colorectal cancer: prevention and treatment by potential natural products","volume":"368","author":"Islam","year":"2022","journal-title":"Chem.-Biol. Interact."},{"issue":"7","key":"10.1016\/j.prp.2025.155876_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00120-021-01569-7","article-title":"Management of chemotherapy side effects and their long-term sequelae","volume":"60","author":"Zraik","year":"2021","journal-title":"Der Urol. Ausg. A"},{"key":"10.1016\/j.prp.2025.155876_bib13","article-title":"Plant-derived bioactive compounds in colon cancer treatment: an updated review","volume":"153","author":"Esmeeta","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2025.155876_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1096008","article-title":"Herbal medicine and its impact on the gut microbiota in colorectal cancer","volume":"13","author":"Bu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.prp.2025.155876_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00384-012-1551-2","article-title":"Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft\u2014no benefit of combination therapy","volume":"28","author":"Wehler","year":"2013","journal-title":"Int. J. Colorectal Dis."},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib16","first-page":"40","article-title":"The action of active efflux system on multi-drug resistance in methicillin resistant Staphylococcus aureus]","volume":"30","author":"Mo","year":"2007","journal-title":"Zhonghua jie he he hu xi za zhi =\u2009Zhonghua jiehe he huxi zazhi =\u2009Chin. J. Tuberc. Respir. Dis."},{"key":"10.1016\/j.prp.2025.155876_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.phytochem.2015.07.012","article-title":"Gingerols and shogaols: Important nutraceutical principles from ginger","volume":"117","author":"Semwal","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.prp.2025.155876_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117733","article-title":"Pharmacodynamic components and mechanisms of ginger (Zingiber officinale) in the prevention and treatment of colorectal cancer","author":"Xiang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.prp.2025.155876_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41110-022-00166-8","article-title":"Therapeutic potential of ginger bio-active compounds in gastrointestinal cancer therapy: the molecular mechanism","volume":"47","author":"Mathur","year":"2022","journal-title":"Nutrirents"},{"issue":"6","key":"10.1016\/j.prp.2025.155876_bib20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S1734-1140(10)70380-7","article-title":"Chemopreventive and antioxidant efficacy of (6)-paradol in 7, 12-dimethylbenz (a) anthracene induced hamster buccal pouch carcinogenesis","volume":"62","author":"Suresh","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"8","key":"10.1016\/j.prp.2025.155876_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.bmcl.2017.02.047","article-title":"Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism","volume":"27","author":"Kim","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/ijms18010168","article-title":"6-Paradol and 6-shogaol, the pungent compounds of ginger, promote glucose utilization in adipocytes and myotubes, and 6-paradol reduces blood glucose in high-fat diet-fed mice","volume":"18","author":"Wei","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.155876_bib23","first-page":"598","article-title":"Culture characteristics of four permanent lines of human cancer cells","volume":"15","author":"Moore","year":"1955","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.prp.2025.155876_bib24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.prp.2025.155876_bib25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0277-5379(91)90142-Z","article-title":"Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing","volume":"27","author":"Keepers","year":"1991","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2025.155876_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1969.56","article-title":"Dose-response curves for agents that impair cell reproductive integrity. The relation between dose-response curves and the design of selective regimens in cancer chemotherapy","volume":"23","author":"Berenbaum","year":"1969","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2025.155876_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin. Colon Rectal Surg."},{"issue":"6","key":"10.1016\/j.prp.2025.155876_bib28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ijc.20032","article-title":"ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases","volume":"109","author":"Candeil","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.prp.2025.155876_bib29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2025.155876_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108386","article-title":"Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics","author":"Mukkavilli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.155876_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"issue":"2","key":"10.1016\/j.prp.2025.155876_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.109.056523","article-title":"Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and-independent mechanisms","volume":"76","author":"Walker","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2025.155876_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijc.10146","article-title":"Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-XL in addition to Bax and p53 status","volume":"98","author":"Violette","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2025.155876_bib34","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/ijc.25498","article-title":"Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo","volume":"127","author":"Wei","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/1471-2407-10-560","article-title":"The multikinase inhibitor sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B-and T-lymphoblastic cells","volume":"10","author":"Schult","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2014.10.012","article-title":"Oncogenic c-Myc and prothymosin-alpha protect hepatocellular carcinoma cells against sorafenib-induced apoptosis","volume":"93","author":"Lin","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.prp.2025.155876_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3835(98)00253-5","article-title":"Induction of apoptosis in HL-60 cells by pungent vanilloids,[6]-gingerol and [6]-paradol","volume":"134","author":"Lee","year":"1998","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2007.05.006","article-title":"Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death","volume":"12","author":"Ricci","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2025.155876_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(01)00781-9","article-title":"Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells","volume":"177","author":"Keum","year":"2002","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.prp.2025.155876_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.prp.2025.155876_bib41","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1039\/b9pp00086k","article-title":"Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells","volume":"8","author":"Jend\u017eelovsk\u00fd","year":"2009","journal-title":"Photochem. Photobiol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2025.155876_bib42","first-page":"414","article-title":"Zingiber officinale Roscoe (ginger) as an adjuvant in cancer treatment: a review","volume":"16","author":"Pereira","year":"2010","journal-title":"J. BU ON: Off. J. Balk. Union Oncol."},{"issue":"8","key":"10.1016\/j.prp.2025.155876_bib43","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1535-7163.MCT-12-0215","article-title":"New use for an old drug: inhibiting ABCG2 with sorafenib","volume":"11","author":"Wei","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2025.155876_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/736431","article-title":"Pharmacokinetic interactions of herbs with cytochrome P450 and P-glycoprotein","volume":"2015","author":"Cho","year":"2015","journal-title":"Evid.-Based Complement. Altern. Med."},{"issue":"5","key":"10.1016\/j.prp.2025.155876_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/1389200033489389","article-title":"Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data","volume":"4","author":"Benet","year":"2003","journal-title":"Curr. Drug Metab."},{"issue":"9","key":"10.1016\/j.prp.2025.155876_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108386","article-title":"Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics","volume":"9","author":"Mukkavilli","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.prp.2025.155876_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ctrv.2009.08.004","article-title":"Clinical pharmacokinetics of tyrosine kinase inhibitors","volume":"35","author":"van Erp","year":"2009","journal-title":"Cancer Treat. Rev."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:26:08Z","timestamp":1778538368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S0344033825000688"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155876","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Paradol enhances sorafenib's effects against colorectal cancer and promotes active metabolite formation","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155876"}}